Britain's leading pharma company AstraZeneca, which has provided the vaccine worldwide during the Covid pandemic, has started recalling it from the market. Many complaints of blood clotting and low platelet count have been registered against its vaccine 'Vaxjaveria'. However, the company has claimed in the statement that a new version of the vaccine is available, hence the old stock has started being ordered.
Serum Institute of India, in collaboration with AstraZeneca, had made 'Covishield' vaccine available in India. AstraZeneca developed the Covid-19 vaccine in collaboration with Oxford University. It was made available as Vaxjavria in Europe and Covishield in India.
The European Union (EU) drug regulator the European Medicines Agency issued a notice on Tuesday confirming that Vaxzevria is no longer authorized for use in the 27-member economic bloc.
The company had decided to recall the vaccine in March itself. It said the marketing authority is working with regulatory authorities around the world to seek the recall of Vaxzeveria.
The company has accepted side effects in rare cases: According to global media reports, earlier AstraZeneca had admitted that its COVID-19 vaccine could cause side effects in rare cases. Which is called thrombosis with thrombocytopenia syndrome (TTS). More than 2.20 billion doses of COVID-19 vaccines have been administered in India and the majority of them were Covishield. Some people have also complained about the side effects of Covishield.
More than three billion doses are supplied globally
The company said that according to independent estimates, more than 65 lakh lives were saved in the first year of use alone, and more than three billion doses were supplied globally. That said, our efforts have been recognized by governments around the world and are widely recognized as a critical component of ending the global pandemic. Many cases are going on in the British court regarding the side effects of AstraZeneca.
Stop supply in December 2021 itself
Pune-based Serum Institute of India (SII) on Wednesday said it had stopped manufacturing and supplying additional doses of Covishield in December 2021. AstraZeneca has voluntarily withdrawn "marketing". Its Covid vaccine, sold as Covishield in India and Vaxjavria in Europe, has been approved.
Russian President Vladimir Putin arrived in Delhi on Thursday evening and headed straight to Prim
Prime Minister Narendra Modi is on a two-day visit to Gujarat. He started it with a road show in
After the Supreme Court's order regarding stray dogs, the exercise to implement the guidelines ha
The most awaited teaser of Sonu Sood's film 'Fateh' has finally been released. The teaser of the
IND vs AUS 5th Test: Big blow to Indian team before Sydney Test match, star bowler out due to injury
India vs Australia's five-match Test series is currently tied at 1-1. The fifth and last match of
The US Embassy in India on Tuesday warned international students studying in the US that their st
There is an atmosphere of panic in Pakistan after India attacked Pakistan. Now, several explosion
Former Indian cricketer Mohammad Kaif said that Indian Test batsmen are struggling at home due to
Paresh Rawal did not get the script of Hera Pheri 3, Akshay Kumar does not have the rights?
Hera Pheri 3 is one of the most anticipated films to date which has been in the news since its an
PAK Boycott Asia Cup: Pakistan packs its bags even without the boycott! Understand how easily
The difficulties of the Pakistan cricket team have increased in the Asia Cup 2025. After sufferin
